definiens: shall mean the direct costs and expenses for mark eting, promotion, advertising ( * * * * ), promotional materials, professional educati on, medical support to marketing activities, Phase IV clinical trials ( solely to the extent any such trials are : ( i ) conducted in support of approved indications in the Field, ( ii ) not intended to result in a labeling change, a nd ( iii ) not required by any Regulatory Authority ), public relations, and other similar activities directly re lated to the Product . Such costs will not include * * * * but will include * * * * incurred by Kos ( including the foregoi ng costs incurred by subcontractors, co - promotion p artners, or consultants of Kos retained pursuant to Section 5.5 and reimbursed by Kos ) which relate directly to the Marketing Costs of the Product and shall be in addi tion to any * * * *